Icure Pharmaceutical Incorporation Balance Sheet Health
Financial Health criteria checks 1/6
Icure Pharmaceutical Incorporation has a total shareholder equity of ₩57.2B and total debt of ₩75.5B, which brings its debt-to-equity ratio to 132.1%. Its total assets and total liabilities are ₩162.6B and ₩105.5B respectively.
Key information
132.1%
Debt to equity ratio
₩75.53b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩6.42b |
| Equity | ₩57.17b |
| Total liabilities | ₩105.45b |
| Total assets | ₩162.62b |
Recent financial health updates
Is Icure Pharmaceutical Incorporation (KOSDAQ:175250) A Risky Investment?
Aug 28
Is Icure Pharmaceutical Incorporation (KOSDAQ:175250) Using Debt In A Risky Way?
May 27We Think Icure Pharmaceutical Incorporation (KOSDAQ:175250) Has A Fair Chunk Of Debt
Dec 25
Recent updates
Is Icure Pharmaceutical Incorporation (KOSDAQ:175250) A Risky Investment?
Aug 28What Icure Pharmaceutical Incorporation's (KOSDAQ:175250) 27% Share Price Gain Is Not Telling You
Jul 21Icure Pharmaceutical Incorporation (KOSDAQ:175250) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
May 31Is Icure Pharmaceutical Incorporation (KOSDAQ:175250) Using Debt In A Risky Way?
May 27Some Shareholders Feeling Restless Over Icure Pharmaceutical Incorporation's (KOSDAQ:175250) P/S Ratio
Mar 07We Think Icure Pharmaceutical Incorporation (KOSDAQ:175250) Has A Fair Chunk Of Debt
Dec 25Financial Position Analysis
Short Term Liabilities: A175250's short term assets (₩30.5B) do not cover its short term liabilities (₩94.0B).
Long Term Liabilities: A175250's short term assets (₩30.5B) exceed its long term liabilities (₩11.4B).
Debt to Equity History and Analysis
Debt Level: A175250's net debt to equity ratio (120.9%) is considered high.
Reducing Debt: A175250's debt to equity ratio has increased from 35.8% to 132.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A175250 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: A175250 has less than a year of cash runway if free cash flow continues to grow at historical rates of 11.9% each year.